← Leaderboards
Kim C Ohaegbulam
Albert Einstein College Of Medicine
$193,416
Attributed
$193,416
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $49K · FY2014–17$50K$37.5K$25K$12.5K$0
'14
'15
'16
'17
Funding mix
By agency
NIH$193,416 · 1
By mechanism
F31$193,416 · 1
Top collaborators
No co-investigators on record.
Most similar at Albert Einstein College Of Medicine
Same institution · by research overlap
- Xingxing Zang$11,384,072
- Maja Hrzenjak Oktay$3,186,669
- Chandan Guha$30,646,840
- Bhaskar Chandra Das$3,457,971
- Michael Berney$7,991,239
Others in their field
Top investigators on “Evolution”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric J Barron · Pennsylvania State Univ University Park$246,372,016
- Everette D Joseph · Howard University$243,972,016
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Antonio J Busalacchi · University Of Maryland, College Park$243,972,016
- David W Simpson · University Of Southern California$231,675,195
Research focus
EvolutionFamily MemberAccelerationAdaptive ImmunityAntibodiesFamilyApoptosisCancer CellCancer ModelCancerousCancer PatientCancer TherapyCd28 GeneBiochemistryBreastCell Cycle ProgressionCellsCellular BiologyChimeric ProteinsCommunitiesCytokineDiagnostic Neoplasm StagingDistant MetastasisGenerations
Grant awards (4)
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy$49,044
F31 · FY2017 · CA · contact PI
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy$48,576
F31 · FY2016 · CA · contact PI
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy$48,120
F31 · FY2015 · CA · contact PI
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy$47,676
F31 · FY2014 · CA · contact PI